about
Plasma D-dimer concentration in patients with systemic sclerosis.Red blood cell distribution width and cardiovascular diseasesAn historical approach to the diagnostic biomarkers of acute coronary syndromeRed cell distribution width and cancerInfluence of the needle bore size on platelet count and routine coagulation testingGenome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.Pathogenesis, laboratory, and clinical characteristics of Helicobacter pylori-associated immune thrombocytopenic purpura.Thirty-minutes' exposure to smartphone call triggers neutrophil activation in vitro.Acute effects of 30 minutes of exposure to a smartphone call on in vitro platelet function.Determinants of anaemia in the very elderly: a major contribution from impaired renal function?Patient posture for blood collection by venipuncture: recall for standardization after 28 years.Non-commutability of results of highly sensitive troponin I and T immunoassays.Influence of a light meal on routine haematological tests.Analytical evaluation of three enzymatic assays for measuring total bile acids in plasma using a fully-automated clinical chemistry platformInfluence of ABO blood group on sports performance.C-reactive protein and venous thromboembolism: causal or casual association?The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer studyEx-vivo red blood cells generation: a step ahead in transfusion medicine?Does laboratory automation for the preanalytical phase improve data quality?The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.Influence of a half-marathon run on NT-proBNP and troponin T.The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerAdvantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetesIron and thrombosisPhlebotomy issues and quality improvement in results of laboratory testing.Quality and reliability of routine coagulation testing: can we trust that sample?Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysisPotential value for new diagnostic markers in the early recognition of acute coronary syndromes.Pathogenesis, clinical and laboratory aspects of thrombosis in cancer.Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.The cost-benefit ratio of screening pregnant women for thrombophilia.Serum ferritin levels correlate with haemoglobin concentration: a report on 589 outpatients from a single centre.The metabolic syndrome and the risk of arterial and venous thrombosis.Genomics and proteomics in venous thromboembolism: building a bridge toward a rational personalized medicine framework.Coagulation testing in pediatric patients: the young are not just miniature adults.Inherited and acquired risk factors for arterial ischemic stroke in childhood.The paradoxical relationship between serum uric acid and cardiovascular disease.A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
P50
Q25257044-8871E2C3-5724-4C56-9716-48AA6D313B19Q26775708-E5A8672A-CD13-44C8-8B94-C6CAA21F9AF1Q27014824-AE3E4069-1E2F-4FCD-9E22-DC6EAF358D75Q28066036-F75F9884-B3F3-4301-A998-4B0A760789E9Q28264577-CBFCEC1E-944C-4E92-80C0-10333710E6BBQ29417122-522FC42C-FE9B-4640-AA37-70F267557ACEQ33378155-ECE43D33-E8E1-4E1E-9821-D2D4871B3E20Q33393886-32A2CAE0-015F-4360-BD74-7D147DDCB534Q33447190-596A3786-EF00-48B8-9078-BDF4EC946CE4Q33448709-00990C79-6D9A-4B2D-9751-15932DCF3F4BQ33603137-3FFBF8C7-2270-4BF1-A024-BFC322BFF975Q33758987-5A528C8B-836D-4A3E-8139-2E8774463B1CQ33773136-E53D536B-0555-424F-8295-1FBBA61FD822Q33775672-8D81FAD9-A6B1-449B-9CEC-979D92E43E87Q33778656-027B9B37-789E-4E3A-9E3C-73B7A8AA774BQ33871562-2C2E3209-334C-4375-A4B7-876AAD3EF51BQ34130906-C248C870-ABCD-44E3-82BD-6D0C736148D5Q34343888-07ED8EAA-E06E-414E-BDC0-B6D1D824D1D1Q34626345-82B31B98-D008-43B0-82A6-280D37AF5CE3Q34728323-7B099650-BF33-41E8-9546-3D7EF098AD75Q34788462-93AA1A0B-BB4D-4D61-A3C4-BD1868893F6CQ34862587-69604619-544A-4587-B1DE-0B87F2CF26F3Q35009171-E57D3DC5-BD5C-4193-8339-44C6985BD856Q35576801-7770D094-110A-4BD5-9CAB-E6B11E4CC0E5Q36159157-E9EACBB9-E9CA-4A6D-99BD-3BAFF0B77C5BQ36428416-F74E0DDC-AA70-460D-A6E1-188DC6C35AE9Q36524246-1E584D37-F22B-4F30-A42F-0085BF59ABDBQ36599827-54ADB2D9-2805-4696-A267-9A9AF07E1450Q36664523-D7E74F6E-4C73-4F4D-B6D1-8835856FA1ABQ36686853-7961BB45-216B-49CA-BF5E-30958EE9AE6AQ36775341-1C2B464C-6F00-40C6-9B02-D6450A5BF486Q36951311-CD9A9F37-F46E-44F3-B2AE-BB6BEA222CDEQ36969463-53B0BCD2-070B-42FC-B2F9-620E7CD6E323Q36969482-CFF69E4B-5112-462B-B927-CDCE6355B015Q36998077-47FFCECC-608E-4D87-9587-25D47380E548Q37050562-5392C1AE-3CD6-4C45-9FB1-FCB1B0A8726CQ37050583-8E2840DA-A334-49A3-838E-D6512210F54EQ37081056-390EBB1E-90DA-4BA4-B343-9D953C6DE535Q37112996-0660097B-1354-4DA7-ABE5-9CDA0212471AQ37130351-186A379F-5D0E-464F-9332-DA59E7D54F24
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8999-0001
@en
name
Martina Montagnana
@ast
Martina Montagnana
@en
Martina Montagnana
@es
Martina Montagnana
@nl
type
label
Martina Montagnana
@ast
Martina Montagnana
@en
Martina Montagnana
@es
Martina Montagnana
@nl
prefLabel
Martina Montagnana
@ast
Martina Montagnana
@en
Martina Montagnana
@es
Martina Montagnana
@nl
P106
P21
P214
44145304384578570965
P31
P496
0000-0001-8999-0001
P734
P735
P7859
viaf-44145304384578570965